Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Tolerability and PK/PD of CXA-10 in Healthy Volunteers
NCT02127190Phase 1Completed
- Sponsor
- Complexa Therapeutics
- Start
- Apr 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in acute kidney injury (AKI) comparing Placebo with CXA-10 (2 arms). Primary endpoint: Number of subjects with Serious and Non-Serious Adverse Events. Started Apr 2014; status: completed.
02
Drugs
10-nitro-oleic acid
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02127190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02127190.